Genix Pharmaceuticals Corp
XTSX:GENX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nihon Jyoho Create Co Ltd
TSE:4054
|
JP |
Genix Pharmaceuticals Corp
Total Current Assets
Genix Pharmaceuticals Corp
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
Total Current Assets
CA$35.2k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-19%
|
|
|
Flora Growth Corp
NASDAQ:FLGC
|
Total Current Assets
$19.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
112%
|
CAGR 10-Years
N/A
|
|
|
Vitality Products Inc
XTSX:VPI
|
Total Current Assets
CA$410.6k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
16%
|
|
|
Jamieson Wellness Inc
TSX:JWEL
|
Total Current Assets
CA$451.3m
|
CAGR 3-Years
9%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
L
|
Leef Brands Inc
CNSX:LEEF
|
Total Current Assets
$10m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Genix Pharmaceuticals Corp
Glance View
Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm focused on developing and licensing novels and products for sales through retail outlets and well as direct to consumers and e-commerce platforms. The firm holds licensing agreement for a range of products, including 30 Ophthalmic drugs, Sucanon, Renochlor, Flu-X, and Levothyroxine sodium (generic Synthroid). Flu-X anti-viral spray is an herbal, oral, anti-viral, anti-flu and anti-cold virus spray. Renochlor is an aid in the restoration of kidney health and kidney function. Sucanon is a natural substitute for prescription pharmaceuticals for non-insulin dependent diabetes patients.
See Also
What is Genix Pharmaceuticals Corp's Total Current Assets?
Total Current Assets
51k
CAD
Based on the financial report for Oct 31, 2025, Genix Pharmaceuticals Corp's Total Current Assets amounts to 51k CAD.
What is Genix Pharmaceuticals Corp's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
-19%
Over the last year, the Total Current Assets growth was 31%. The average annual Total Current Assets growth rates for Genix Pharmaceuticals Corp have been -40% over the past three years , -41% over the past five years , and -19% over the past ten years .
